(Q36488777)

14 August 2017

Sputum biomarkers of inflammation and lung function decline in children with cystic fibrosis (English)

1 reference

14 August 2017

0 references

0 references

0 references

0 references

Edith T Zemanick

5

0 references

Brandie D Wagner

object named as

Brandie D Wagner

2

0 references

author name string

Scott D Sagel

1

1 reference

14 August 2017

Margaret M Anthony

3

1 reference

14 August 2017

Peggy Emmett

4

1 reference

14 August 2017

language of work or name

English

0 references

publication date

16 August 2012

1 reference

American Journal of Respiratory and Critical Care Medicine

14 August 2017

1 reference

14 August 2017

186

1 reference

14 August 2017

9

1 reference

14 August 2017

857-865

1 reference

17beta-Estradiol inhibits Ca2+-dependent homeostasis of airway surface liquid volume in human cystic fibrosis airway epithelia

14 August 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Potential role of high-mobility group box 1 in cystic fibrosis airway disease.

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Sputum biomarkers of inflammation in cystic fibrosis lung disease

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Association between pulmonary function and sputum biomarkers in cystic fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

High-dose oral N-acetylcysteine, a glutathione prodrug, modulates inflammation in cystic fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Mixed models for longitudinal left-censored repeated measures

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Analysis of left-censored longitudinal data with application to viral load in HIV infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Gender differences in cystic fibrosis: Pseudomonas aeruginosa infection

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Standardization of Spirometry, 1994 Update. American Thoracic Society

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Random-effects models for longitudinal data

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Safety and efficacy of recombinant alpha(1)-antitrypsin therapy in cystic fibrosis

30 September 2017

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Microbiology of sputum from patients at cystic fibrosis centers in the United States

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Levels of free granulocyte elastase in bronchial secretions from patients with cystic fibrosis: effect of antimicrobial treatment against Pseudomonas aeruginosa

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Risk factors for rate of decline in forced expiratory volume in one second in children and adolescents with cystic fibrosis

28 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Induced sputum matrix metalloproteinase-9 correlates with lung function and airway inflammation in children with cystic fibrosis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Airway inflammation in children with cystic fibrosis and healthy children assessed by sputum induction

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Longitudinal relationship among growth, nutritional status, and pulmonary function in children with cystic fibrosis: analysis of the Cystic Fibrosis Foundation National CF Patient Registry

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Longitudinal analysis of pulmonary function decline in patients with cystic fibrosis

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Pulmonary function between 6 and 18 years of age.

21 September 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=3530222

Addressing the complexity of chronic obstructive pulmonary disease: from phenotypes and biomarkers to scale-free networks, systems biology, and P4 medicine

21 September 2018

1 reference

Crossref

https://api.crossref.org/works/10.1164%2FRCCM.201203-0507OC

alpha1-Antitrypsin inhalation reduces airway inflammation in cystic fibrosis patients

21 January 2018

1 reference

12 December 2020

Elastin and collagen degradation products in urine of patients with cystic fibrosis

1 reference

12 December 2020

Aerosol α1 -antitrypsin treatment for cystic fibrosis

1 reference

12 December 2020

Prolastin aerosol therapy and sputum taurine in cystic fibrosis

1 reference

12 December 2020

Sputum peroxidase activity correlates with the severity of lung disease in cystic fibrosis

1 reference

12 December 2020

Induced sputum inflammatory measures correlate with lung function in children with cystic fibrosis

1 reference

12 December 2020

Genetic modifiers of lung disease in cystic fibrosis

1 reference

12 December 2020

Sputum induction in routine clinical care of children with cystic fibrosis

1 reference

12 December 2020

Sputum and serum calprotectin are useful biomarkers during CF exacerbation

1 reference

12 December 2020

Effect of Treatment with Dornase Alpha on Airway Inflammation in Patients with Cystic Fibrosis

1 reference

12 December 2020

Predictors of deterioration of lung function in cystic fibrosis

1 reference

12 December 2020

alpha 1-Proteinase inhibitor, elastase activity, and lung disease severity in cystic fibrosis

1 reference

12 December 2020

Biochemical and pathologic evidence for proteolytic destruction of lung connective tissue in cystic fibrosis

1 reference

12 December 2020

Pulmonary function is negatively correlated with sputum inflammatory markers and cough clearability in subjects with cystic fibrosis but not those with chronic bronchitis

1 reference

12 December 2020

Bronchoalveolar lavage findings in cystic fibrosis patients with stable, clinically mild lung disease suggest ongoing infection and inflammation

1 reference

12 December 2020

10.1164/RCCM.201203-0507OC

Identifiers

DOI

1 reference

14 August 2017

1 reference

14 August 2017

PubMed publication ID

22904182

1 reference